ClinVar Miner

Submissions for variant NM_000543.5(SMPD1):c.785_807del (p.Leu262fs)

dbSNP: rs794727252
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000175621 SCV000227145 pathogenic not provided 2017-04-27 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000984223 SCV000918248 pathogenic Niemann-Pick disease, type B 2021-02-08 criteria provided, single submitter clinical testing Variant summary: SMPD1 c.785_807del23 (p.Leu262ArgfsX4) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 4e-06 in 249834 control chromosomes. The variant, c.785_807del23, has not, to our knowledge, been reported in the literature in individuals affected with Niemann-Pick Disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.
Invitae RCV001065527 SCV001230486 pathogenic Niemann-Pick disease, type B; Niemann-Pick disease, type A 2023-09-08 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Leu262Argfs*4) in the SMPD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SMPD1 are known to be pathogenic (PMID: 12369017, 15221801). This variant is present in population databases (rs794727252, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with SMPD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 195086). For these reasons, this variant has been classified as Pathogenic.
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV001248878 SCV001422554 pathogenic Sphingomyelin/cholesterol lipidosis 2020-01-22 criteria provided, single submitter curation The p.Leu262ArgfsTer4 variant in SMPD1 (also known as p.Leu260ArgfsTer4 due to a difference in cDNA numbering) has been reported in at least 2 individuals with Niemann-Pick disease (PMID: 12712061, 15234149, 12369017, 17011332) and has been identified in 0.008% (2/24384) of African chromosomes and 0.001% (1/128550) of European (non-Finnish) chromosomes the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs794727252). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (VariationID: 195086) as pathogenic by EGL Genetic Diagnostics and as likely pathogenic by Integrated Genetics. This variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at position 262 and leads to a premature termination codon 4 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the SMPD1 gene is an established disease mechanism in autosomal recessive Niemann-Pick disease. The presence of this variant in combination with reported pathogenic variants in 2 individuals with Niemann-Pick disease increases the likelihood that the p.Leu262ArgfsTer4 variant is pathogenic (VariationID: 93315 198093; PMID: 12712061, 15234149, 12369017, 17011332). In summary, this variant meets criteria to be classified as pathogenic for Niemann-Pick disease in an autosomal recessive manner based on the prediction that it causes loss of function, its presence in combination with other pathogenic variants in affected individuals, and its low frequency in the general population. ACMG/AMP Criteria applied: PVS1, PM2, PM3 (Richards 2015).
GeneDx RCV000175621 SCV001767818 pathogenic not provided 2020-03-09 criteria provided, single submitter clinical testing Has not been previously published as pathogenic or benign to our knowledge; Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 23418865)
Fulgent Genetics, Fulgent Genetics RCV001065527 SCV002809831 pathogenic Niemann-Pick disease, type B; Niemann-Pick disease, type A 2021-10-02 criteria provided, single submitter clinical testing
Baylor Genetics RCV000984222 SCV004203223 pathogenic Niemann-Pick disease, type A 2024-02-26 criteria provided, single submitter clinical testing
Counsyl RCV000984222 SCV001132296 likely pathogenic Niemann-Pick disease, type A 2014-01-02 no assertion criteria provided clinical testing
Counsyl RCV000984223 SCV001132297 likely pathogenic Niemann-Pick disease, type B 2014-01-02 no assertion criteria provided clinical testing
Natera, Inc. RCV000984222 SCV002091696 pathogenic Niemann-Pick disease, type A 2017-08-03 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.